导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 27.78% | 1/9 |
| 近一周 | -2.03% | 4/9 |
| 近一月 | -8.16% | 6/9 |
| 近一季 | -8.21% | 5/9 |
| 近半年 | 28.19% | 1/9 |
| 近一年 | 40.15% | 1/9 |
| 近两年 | 150.13% | 1/9 |
| 近三年 | 127.88% | 1/9 |
| 成立以来 | 336.68% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.07% 2114/5130 |
43.35% 1232/5464 |
- - |
- - |
| 2025 | 65.85% 379/5130 |
-3.77% 4394/4624 |
1.37% 2670/4802 |
57.32% 237/4970 |
8.07% 312/5130 |
| 2024 | 6.27% 1545/4618 |
-1.55% 1809/4340 |
-0.07% 1391/4442 |
11.58% 1756/4550 |
-3.20% 2543/4618 |
| 2023 | -4.96% 538/4216 |
5.64% 873/3759 |
1.37% 491/3909 |
-10.06% 2522/4055 |
-1.32% 787/4209 |
| 2022 | -34.18% 2553/3578 |
-22.13% 2354/2804 |
3.49% 2281/3205 |
-14.22% 2169/3430 |
-4.79% 2560/3570 |
| 2021 | -3.31% 1137/2717 |
-9.80% 1438/1745 |
17.48% 464/2232 |
-4.44% 1150/2560 |
-4.52% 2095/2708 |
| 2020 | 75.34% 215/1596 |
-1.93% 538/1036 |
37.88% 66/1256 |
9.88% 689/1472 |
18.02% 424/1690 |
| 2019 | 46.84% 288/926 |
26.04% 832/3054 |
-2.90% 2174/3201 |
8.34% 307/939 |
10.75% 288/1014 |
| 2018 | -31.85% 457/668 |
- - |
- - |
- - |
-13.27% 2541/2977 |
| 2017 | 12.02% 270/531 |
- - |
- - |
- - |
- - |
| 2016 | -22.35% 334/455 |
- - |
- - |
- - |
- - |
| 2015 | 60.73% 117/433 |
- - |
- - |
- - |
- - |
| 2014 | 11.77% 339/432 |
- - |
- - |
- - |
- - |
| 2013 | 60.43% 7/398 |
- - |
- - |
- - |
- - |
| 2012 | 20.09% 8/459 |
- - |
- - |
- - |
- - |
| 2011 | -23.67% 194/392 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 56.52% |
| 招商创新增长混合A | 1.0759 | 55.91% |
| 招商创新增长混合C | 1.0235 | 55.61% |
| 招商品质成长混合A | 1.0435 | 55.01% |
| 华泰柏瑞医疗健康A | 2.6422 | 50.99% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 48.05% |
| 大摩优悦安和混合C | 0.8828 | 47.91% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 中信建投医药健康C | 0.7579 | 39.35% |
| 华宝新兴产业混合 VS. 长安宏观策略混合A(740001) |